Inhibitors
Inhibitors are molecules that bind to enzymes, receptors, or other proteins to reduce or block their biological activity. These compounds are widely used in research to study biological pathways, understand disease mechanisms, and develop therapeutic drugs. Inhibitors play a crucial role in the treatment of various diseases, including cancer, cardiovascular diseases, and infections. At CymitQuimica, we provide a diverse range of high-quality inhibitors to support your research in biochemistry, cell biology, and pharmaceutical development.
Subcategories of "Inhibitors"
- Angiogenesis(2,849 products)
- Apoptosis(6,366 products)
- Cell Cycle/Checkpoint(4,907 products)
- Chromatin/Epigenetics(2,623 products)
- Cytoskeletal Signaling(1,585 products)
- DNA Damage/DNA Repair(2,872 products)
- Endocrinology/Hormones(3,759 products)
- Enzyme(3,673 products)
- GPCR/G-Protein(9,051 products)
- Immunology and Inflammation(3,945 products)
- Influenza Virus(300 products)
- JAK/STAT signaling(417 products)
- MAPK Signaling(1,259 products)
- Membrane Transporter/Ion Channel(3,162 products)
- Metabolism(10,149 products)
- Microbiology/Virology(7,672 products)
- Neuroscience(10,549 products)
- Other Inhibitors(35,857 products)
- Oxidation-Reduction(41 products)
- PI3K/Akt/mTOR Signaling(1,435 products)
- Proteases/Proteasome(1,693 products)
- Stem Cell and Derivatives(734 products)
- Tyrosine Kinase/Adaptors(1,991 products)
- Ubiquitination(1,743 products)
Show 16 more subcategories
Found 66517 products of "Inhibitors"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Anti-inflammatory agent 18
Anti-inflammatory agent 18: NO activity blocker (IC50: 15.94 μM), hampers HMGB1-induced inflammation, potential for COVID-19, sepsis study.Formula:C30H50O6Color and Shape:SolidMolecular weight:506.71PIM-1/HDAC-IN-1
PIM-1/HDAC-IN-1 (4d): inhibits PIM-1 (IC50: 343.87nM), HDAC1 (63.65nM), HDAC6 (62.39nM); induces apoptosis in MCF-7 cells.Formula:C22H19N3O3Color and Shape:SolidMolecular weight:373.4Antileishmanial agent-5
Antileishmanial agent-4, a ribonucleoside analogue, targets L.infantum and T.cruzi with EC50s of 0.68 μM and 0.83 μM.Formula:C17H17ClN4O4Color and Shape:SolidMolecular weight:376.79HIV-1 inhibitor-13
HIV-1 inhibitor-13: oral NNRTI, IC50=0.14μM for HIV-1 RT, effective on resistant strains (EC50=2.85-18nM).Formula:C30H32N6O3Color and Shape:SolidMolecular weight:524.61Basroparib
CAS:Basroparib is an inhibitor of ribose polymerase (PARP) and has shown antitumour effects.Formula:C18H21F2N7O3Color and Shape:SolidMolecular weight:421.4PDE4B-IN-3
PDE4B-IN-3 is a potent inhibitor of PDE4B (IC50: 0.94 μM) and exhibits anti-inflammatory effects.Formula:C30H35N3O4S2Color and Shape:SolidMolecular weight:565.75RS 12254
CAS:RS 12254 is a dopamine agonist and antihypertensive agent.Formula:C28H40N2O4Purity:98%Color and Shape:SolidMolecular weight:468.63AChE/PDE4-IN-1
AChE/PDE4-IN-1, compound 12c, dual inhibitor; IC50: 0.28μM for AChE, 1.88μM for PDE4D, may reduce Alzheimer's neuroinflammation.Formula:C23H28N2O3Color and Shape:SolidMolecular weight:380.48Antibacterial agent 62
Novel anti-TB agent 62 is a redox compound with bactericidal activity against active and dormant bacteria.Formula:C24H33BrN2O2Color and Shape:SolidMolecular weight:461.44NLRP3-IN-4
NLRP3-IN-4 is an effective, oral NLRP3 inflammasome inhibitor with potent anti-inflammatory effects on colitis.Formula:C22H22N2O5Color and Shape:SolidMolecular weight:394.42VEGFR-2-IN-17
VEGFR-2-IN-17 (15a) is a potent VEGFR-2 inhibitor with an IC50 of 67.25 nM, showing significant antitumor effects.Formula:C21H14ClN3O2Color and Shape:SolidMolecular weight:375.81iMDK quarterhydrate
iMDK quarterhydrate, PI3K inhibitor, blocks MDK growth; suppresses NSCLC safely with MEK inhibitor.Formula:C21H15FN2O3SColor and Shape:SolidMolecular weight:380.91AP5 sodium
CAS:AP5 sodium: potent oral GPR40 agonist, enhances ligands, may aid type II diabetes research.Formula:C28H27FNNaO4Color and Shape:SolidMolecular weight:483.515ALK-IN-23
ALK-IN-23 inhibits ALK (IC50: 1.6-0.71 nM), hinders cancer cell spread, forms colonies in vitro, and reduces tumors in mice with low toxicity.Formula:C26H29ClN8O3SColor and Shape:SolidMolecular weight:569.08GID4 Ligand 1
GID4 Ligand 1: cell-permeable, selective binder, IC50 5.4 μM, Kd 5.6 μM, binds in cells with EC50 558 nM, useful for PROTAC synthesis.
Formula:C28H34N4O5SColor and Shape:SolidMolecular weight:538.66CYP2C9/CYP2C19-IN-1
CYP2C9/CYP2C19-IN-1 is a potent inhibitor of CYP2C9/CYP2C19 without liver toxicity or genotoxicity and can be used to study Zika virus (ZIKV) infection.Formula:C27H28N2O6SColor and Shape:SolidMolecular weight:508.59MDL-100173
CAS:MDL-100173 is a dual angiotensin-converting enzyme (ACE)/neutral endopeptidase (NEP) inhibitor.Formula:C24H26N2O4SColor and Shape:SolidMolecular weight:438.54MAP855
CAS:MAP855: potent, selective, oral MEK1/2 inhibitor; IC50=3 nM, pERKEC50=5 nM; effective on wild-type/mutant MEK1/2.Formula:C28H23ClF2N6O3Color and Shape:SolidMolecular weight:564.97MALT1-IN-11
CAS:MALT1-IN-11: MALT1 inhibitor, IC50 <10-100 nM, reduces IL10, for cancer/autoimmune research.Formula:C20H16F4N8OColor and Shape:SolidMolecular weight:460.39Antitubercular agent-15
Antitubercular agent-15 (5n): low toxicity, fights M. tuberculosis strains; MIC90 values range 0.73-18.8 μg/mL.Formula:C21H29FN2Color and Shape:SolidMolecular weight:328.47(S)-JDQ-443
CAS:(S)-JDQ-443, an isomer of JDQ-443, is a selective, potent oral KRAS G12C inhibitor with antitumor properties.Formula:C29H28ClN7OColor and Shape:SolidMolecular weight:526.03CD73-IN-12
CD73-IN-12, a compound from CN114437038A, shows strong anti-tumor activity by effectively inhibiting CD73 enzyme.Formula:C17H14F2N4O2Color and Shape:SolidMolecular weight:344.32p38-α MAPK-IN-5
CAS:p38-α MAPK-IN-5: potent p38α inhibitor, IC50s: 0.1 nM (α), 0.2 nM (β), 944 nM (γ), 4100 nM (δ); anti-inflammatory, promising for asthma/COPD research.Formula:C37H49N11O2Color and Shape:SolidMolecular weight:679.86RET-IN-1
CAS:RET-IN-1 is a RET kinase inhibitor (IC50s: 1 nM, 7 nM, and 101 nM for RET (WT), RET (V804M) , and RET (G810R), respectively).Formula:C29H31N9O3Purity:98%Color and Shape:SolidMolecular weight:553.61ACHN-975
CAS:ACHN-975: potent LpxC inhibitor with subnanomolar activity; targets many gram-negative bacteria; MIC ≤1 μg/mL.Formula:C20H23N3O4Purity:98%Color and Shape:SolidMolecular weight:369.41HIF-2α-IN-7
CAS:HIF-2α-IN-7 is a hypoxia inducible factor 2α (HIF-2α) inhibitor.Formula:C18H9F6NO2Color and Shape:SolidMolecular weight:385.26L-2'-Fd4C
CAS:L-2'-Fd4C is an L-nucleoside analogue with both anti-human immunodeficiency virus (HIV) and anti-hepatitis B virus (HBV) activity [1].Formula:C9H10FN3O3Color and Shape:SolidMolecular weight:227.19Antitumor agent-58
Antitumor agent-58 suppresses tumor growth, colony formation, cell migration, and induces mitochondrial dysfunction in MGC-803 cells.Formula:C27H28F3N9SColor and Shape:SolidMolecular weight:567.63CXCR2 antagonist 5
CXCR2 antagonist 5 (compound 25) binds strongly (IC50=0.013μM) and mobilizes calcium (IC50=0.1μM).
Formula:C15H14F2N4O2SColor and Shape:SolidMolecular weight:352.36Antibacterial agent 63
CAS:Aztreonam-siderophore conjugate 63 is an antibacterial agent that exhibits efficacy against Gram-negative bacteria through the linkage of aztreonam to aFormula:C35H43N9O14S2Color and Shape:SolidMolecular weight:877.9Anticancer agent 45
Anticancer agent 46, potent and selective, induces apoptosis, is cytotoxic to cancer cells, with low toxicity to human lymphocytes.Formula:C22H14ClN3O6S2Color and Shape:SolidMolecular weight:515.95AFM-30a hydrochloride
AFM-30a hydrochloride: selective PAD2 inhibitor, EC50 9.5 μM; blocks H3 guanylation, EC50 0.4 μM; used for cancer and autoimmune research.Formula:C24H28ClFN6O3Color and Shape:SolidMolecular weight:502.97L162389
CAS:L162389 is an angiotensin II receptor antagonist with a balanced affinity for AT1 and AT2 receptor and stimulates the conversion of phosphatidylinositol.Formula:C31H38N4O4SPurity:99.11% - 99.57%Color and Shape:SolidMolecular weight:562.72EGFR/HER2/DHFR-IN-1
Potent EGFR/HER2/DHFR inhibitor for MCF-7 breast cancer; IC50: 0.153/0.108/0.291 μM; arrests G1/S phase, triggers apoptosis.Formula:C14H11BrN4O2SColor and Shape:SolidMolecular weight:379.23Anticancer agent 64
CAS:Anticancer agent 64 (5m) induces apoptosis, has IC50 2.4μM in CCRF-CEM, activates caspases, cleaves PARP, affects mitochondria.Formula:C31H46N2O2SColor and Shape:SolidMolecular weight:510.77ZIKV-IN-4
ZIKV-IN-4 is a low cytotoxic, acid-stable anti-ZIKV agent with an EC50 value of 3.49 μM. ZIKV-IN-4 exhibited potent inhibition of ZIKV NS5 MTase.Formula:C33H37NO4Color and Shape:SolidMolecular weight:511.65β-Secretase Inhibitor III
β-Secretase Inhibitor III is a highly selective inhibitor of BACE1 with a Ki value of 0.13 nM.Formula:C20H20F2N4O3SColor and Shape:SolidMolecular weight:434.46FGFR-IN-6
CAS:FGFR-IN-6 (Compound 5) is an FGFR inhibitor.Formula:C23H22N6O3Color and Shape:SolidMolecular weight:430.46BI-4916
CAS:BI-4916 is a phosphoglycerate dehydrogenase (PHGDH) inhibitor that inhibits SSP and reduces cancer cell migration.Formula:C23H24Cl2N2O6SPurity:98.55% - 98.55%Color and Shape:SolidMolecular weight:527.42Hypoglycemic agent 1
CAS:Hypoglycemic agent 1 has an action for lowering blood sugar. It acts as a therapeutic and/or prophylactic agent for diabetes.Formula:C25H24FN5O4Purity:98%Color and Shape:SolidMolecular weight:477.49NYX-2925
CAS:NYX-2925, an oral NMDAR modulator, enhances Src in mPFC. No CAMKII impact or addictive/sedative effects. Useful for CNS disorder studies.Formula:C14H23N3O4Color and Shape:SolidMolecular weight:297.35MY-875
MY-875 inhibits microtubule formation, binds like colchicine (IC50: 0.92 μM), activates Hippo pathway, and induces apoptosis with anticancer properties.Formula:C21H25NO6Color and Shape:SolidMolecular weight:387.43Resolvin D1 methyl ester
CAS:Resolvin D1, from docosahexaenoic acid via 15-/5-lipoxygenase, curbs acute inflammation; EC50 ~30 nM. Its methyl ester may enhance bioavailability.Formula:C23H34O5Color and Shape:SolidMolecular weight:390.51IRAK4-IN-11
IRAK4-IN-11 (compound 6) is a potent inhibitor of IRAK4 with an IC 50 of 0.008 μM. IRAK4-IN-11 exhibits cell pIRAK4 potencies with an IC 50 of 0.19 μM [1].Formula:C16H19N7OColor and Shape:SolidMolecular weight:325.37DNA-PK-IN-2
CAS:DNA-PK-IN-2 is an inhibitor of the DNA-PK enzyme complex, useful in cancer research.Formula:C20H23N5O3Color and Shape:SolidMolecular weight:381.43M826
M826, a non-peptide, potent, selective, and reversible caspase-3 inhibitor, exhibits an IC50 of 0.005 μM and demonstrates strong anti-apoptotic activity inFormula:C28H45N7O6Purity:98%Color and Shape:SolidMolecular weight:575.7Serlopitant
CAS:Serlopitant is a selective antagonist of Neurokinin-1 (NK-1) receptor.Formula:C29H28F7NO2Color and Shape:SolidMolecular weight:555.53Anticancer agent 14
Anticancer agent 14: a potent breast cancer inhibitor; induces cell death, disrupts mito. membrane potential (IC50: 0.20-0.65 μM).Formula:C29H34N2O3Color and Shape:SolidMolecular weight:458.59α-Glucosidase-IN-19
Alpha-Glucosidase-IN-19 (Compound 6B) is an orally active alpha-glucosidase inhibitor (IC50: 3.63 μM) with antidiabetic effects.Formula:C31H25NOSColor and Shape:SolidMolecular weight:459.6BAY-3153
CAS:BAY-3153 is a selective CCR1 ( C-C motif chemokine receptor 1 ) antagonist (human IC 50 =3 nM ; rat IC 50 =11 nM ; mice IC 50 =81 nM) .Formula:C25H29Cl2N3O4Purity:98%Color and Shape:SolidMolecular weight:506.42AVE-1330A sodium
CAS:AVE-1330A sodium is a beta-Lactamase inhibitor.Formula:C7H10N3NaO6SColor and Shape:SolidMolecular weight:287.23FAAH/MAGL-IN-2
CAS:FAAH/MAGL-IN-2: potent, reversible, oral FAAH & MAGL inhibitor, IC50: 11/36 nM, may research neuropathic pain, no locomotion issue.Formula:C15H13Cl2N3O3SColor and Shape:SolidMolecular weight:386.25Nrf2/HO-1 activator 1
CAS:Compound 24: Potent Nrf2/HO-1 activator with neuroprotective, antioxidant properties; useful in PD research.Formula:C21H18O5Color and Shape:SolidMolecular weight:350.36Colistin adjuvant-1
Colistin adjuvant-1, inhibits NF-κB (IC50: 0.209 μM), boosts mucin against gram-negative bacteria.Formula:C16H7F9N2OColor and Shape:SolidMolecular weight:414.23GPX100 HCl
CAS:GPX-100, a non-cardiotoxic doxorubicin analog, intercalates DNA and inhibits replication, repair, and protein synthesis.Formula:C27H32ClNO10Color and Shape:SolidMolecular weight:566LGB-321 HCl
CAS:LGB-321: potent, selective PIM kinase inhibitor, active against PIM2, halts diverse blood cancers' growth, orally effective in mice.Formula:C23H23ClF3N5O2Color and Shape:SolidMolecular weight:493.91Gemilukast
CAS:Gemilukast (ONO-6950) is a cysteinyl leukotriene 1 and 2 receptor inhibitor that inhibits bronchoconstriction and is used in the treatment of asthma.Formula:C36H37F2NO5Purity:98.27% - 99.5%Color and Shape:SolidMolecular weight:601.68Ref: TM-T11388
1mg109.00€5mg260.00€1mL*10mM (DMSO)344.00€10mg447.00€25mg865.00€50mg1,341.00€100mg2,385.00€GRPR antagonist-2
GRPR antagonist-2 blocks GRPR, kills some cancer cells, effective on HGC-27 (IC50: 0.77 μM) & Pan02 (IC50: 2.5 μM).Formula:C28H32F3N5O4Color and Shape:SolidMolecular weight:559.58GR-71251
CAS:GR-71251 is a Tachykinin receptor antagonist.
Formula:C74H105N19O13Color and Shape:SolidMolecular weight:1468.74AZD4625
AZD4625 (Compound 21) is a selective, potent, orally active, covalent and mutagenic mutant GTPaseKRASG12C inhibitor.Formula:C24H21ClF2N4O3Color and Shape:SolidMolecular weight:486.9ZD6021
CAS:ZD6021 is an antagonist of neurokinin 1 receptor.Formula:C35H35Cl2N3O2SPurity:98%Color and Shape:SolidMolecular weight:632.64Antitumor agent-54
Compound C11 inhibits 14-3-3η protein (KD: 35 μM), targets liver cancer cells, blocks G1-S phase, and induces apoptosis.Formula:C29H32N2O3Color and Shape:SolidMolecular weight:456.58BMS-986339
CAS:BMS-986339: oral, potent FXR agonist; binds to His298/ASN287; for PBC, PSC, NASH, anti-fibrosis research.Formula:C35H41F4N3O4Color and Shape:SolidMolecular weight:643.71Onfasprodil
CAS:Onfasprodil, NR2B inhibitor & GABA regulator, potential for Alzheimer's research. (Patent CN111481543A)Formula:C20H23FN2O3Color and Shape:SolidMolecular weight:358.41AP5
CAS:AP5: GPR40 agonist, positive allosteric modulator; rat hIP1 EC50: 0.49 nM.Formula:C28H28FNO4Purity:98%Color and Shape:SolidMolecular weight:461.52A25822B
CAS:A25822B is an antifungal agent.Formula:C28H45NOPurity:98%Color and Shape:SolidMolecular weight:411.66Anti-MRSA agent 2
CAS:Anti-MRSA agent 2 inhibits MRSA at 0.098 μg/ml, with low toxicity and disrupts bacterial membranes and DNA.Formula:C18H10Br2N2OColor and Shape:SolidMolecular weight:430.09T-3861174
CAS:T-3861174 is a prolyl tRNA synthetase (PRS) inhibitor, exhibiting significant in vitro anti-tumor activity with GCN2-ATF4 pathway activation.Formula:C26H25FN6O2Color and Shape:SolidMolecular weight:472.51(R)-BAY-899
(R)-BAY-899: R-isomer, selective LH-R antagonist, effective on hLH (IC50: 185 nM) and rLH (IC50: 46 nM), orally active.Formula:C25H19F2N5O2Color and Shape:SolidMolecular weight:459.45Leukotriene F4
CAS:LTF4, made in vitro from LTE4 with enzymes, contracts vascular muscle weakly; potency is LTD4 > LTC4 > LTE4 >> LTF4.Formula:C28H44N2O8SColor and Shape:SolidMolecular weight:568.72THR-β agonist 4
CAS:THR-β agonist 4 is a potent agonist of THR-β.Formula:C16H11Cl2F2N5O6SColor and Shape:SolidMolecular weight:510.26Avorelin acetate
CAS:Avorelin acetate is a luteinizing hormone releasing hormone (LH-RH) agonist.Formula:C67H89N17O14Color and Shape:SolidMolecular weight:1356.55Carbodine
CAS:Carbodine is an antiviral targeting CTP synthetase, effective against influenza A0/PR-8/34 and A2/Aichi/2/68.Formula:C10H15N3O4Purity:98%Color and Shape:SolidMolecular weight:241.24(-)-Mesembrine
CAS:Mesembrine is a serotonin reuptake inhibitor and is also a weak inhibitor of the enzyme phosphodiesterase 4 (PDE4).Formula:C17H23NO3Color and Shape:SolidMolecular weight:289.37NVP-CFC218
CAS:NVP-CFC218 is a novel potent and selective p53-HDM2 inhibitor.Formula:C37H45ClN4O4Color and Shape:SolidMolecular weight:645.23EGFR/HER2-IN-7
EGFR/HER2-IN-7: Potent, selective dual inhibitor for MCF-7 cancer; IC50: EGFR 0.18μM, HER2 0.146μM, DHFR 0.907μM.Formula:C19H21N3O2SColor and Shape:SolidMolecular weight:355.45EGFR-IN-58
EGFR-IN-58 is a potent, selective, ATP-competitive inhibitor of EGFR. EGFR-IN-58 exhibits significant cytotoxicity against melanoma, colon and blood cancers.Formula:C31H30FN7OColor and Shape:SolidMolecular weight:535.61YK5
CAS:YK5 is an allosteric inhibitor pocket of Hsp70 and represents a previously unknown chemical tool to investigate cellular mechanisms associated with Hsp70.Formula:C18H24N8O3SPurity:98%Color and Shape:SolidMolecular weight:432.50Amrubicin HCl
CAS:Amrubicin (SM-5887), an anthracycline, treats lung cancer by inhibiting DNA replication and topoisomerase II, with less cardiac toxicity.Formula:C25H25NO9Color and Shape:SolidMolecular weight:483.47K20
K20 selectively inhibits KRas G12C (IC50: 1.16 nM), shows anticancer activity in H358 cells (IC50: 0.78 μM), and induces apoptosis via Erk dephosphorylation.Formula:C24H20Cl2F4N4O2Color and Shape:SolidMolecular weight:543.34Verrucarin A
CAS:Verrucarin A, a mycotoxin from Myrothecium verrucaria, inhibits protein synthesis, leukemia growth, and triggers apoptosis.Formula:C27H34O9Color and Shape:SolidMolecular weight:502.55Haspin-IN-2
CAS:Haspin-IN-2 is a potent haspin inhibitor (IC50: 50 nM) and also inhibits CLK1 (IC50: 445 nM) and DYRK1A (IC50: 917 nM).Formula:C12H8N4O3Color and Shape:SolidMolecular weight:256.225-Iminodaunorubicin hydrochloride
CAS:5-Iminodaunorubicin HCl: quinone-modified anthracycline with antitumor properties, induces DNA breaks in cancer cells.Formula:C27H31ClN2O9Color and Shape:SolidMolecular weight:563.00PAIR2
CAS:PAIR2 is a selective IRE1α RNase partial antagonist, blocking its ATP site and preventing KIRA from hindering XBP1 splicing.Formula:C27H26F4N6O3SColor and Shape:SolidMolecular weight:590.59MAFP
CAS:MAFP (Methyl Arachidonyl Fluorophosphonate) is an effective irreversible inhibitor of anandamide amidase.Formula:C21H36FO2PColor and Shape:SolidMolecular weight:370.48BCL6-IN-9
CAS:BCL6-IN-9 (compound 1) is a potent inhibitor of B-cell lymphoma 6 protein (BCL6) (IC50: 3.9 nM) and can be used to study cancer.Formula:C22H18ClF2N5O2Color and Shape:SolidMolecular weight:457.86BET-IN-6
CAS:BET-IN-6: Potent BRD2/4 inhibitor and ligand for PROTAC BRD2/BRD4 degrader-1 synthesis.Formula:C22H20N2O6SPurity:98%Color and Shape:SolidMolecular weight:440.47Vibegron
CAS:Vibegron (MK-4618) is an effective and selective Beta 3 adrenergic receptor agonist, used to treat overactive bladder (OAB).Formula:C26H28N4O3Color and Shape:SolidMolecular weight:444.53RORγt/DHODH-IN-3
RORγt/DHODH-IN-3 (compound (S)-14d) is a potent, orally active dual inhibitor of RORγt (IC50: 0.098 μM) and DHODH (IC50: 0.432 μM).RORγt/DHODH-IN-1 hasFormula:C24H26ClF6N3O3SColor and Shape:SolidMolecular weight:585.99ALOX15-IN-1
ALOX15-IN-1 (8b) inhibits rabbit/human ALOX15; IC50: 0.04 μM for LA, 2.06 μM for AA.Formula:C24H31N3O5SColor and Shape:SolidMolecular weight:473.59Lobaric acid
CAS:Lobaric acid, from Stereocaulon lichen, has antioxidant and anticancer properties, inhibits PTP1B and 12(S)-LOX, and reduces TMV lesions in plants.Formula:C25H28O8Color and Shape:SolidMolecular weight:456.48RMS-07
CAS:RMS-07, a covalent MPS1/TTK inhibitor, has an IC50 of 13.1 nM, targeting a kinase hinge cysteine.Formula:C35H40N8O2Color and Shape:SolidMolecular weight:604.74CH-38083
CAS:CH-38083 is a selective and effective alpha-2 adrenoceptors antagonist.Formula:C18H24ClNO3Purity:98%Color and Shape:SolidMolecular weight:337.84Cleistanthin
CAS:Cleistanthin, a toxic Cleistanthus collinus compound, has antihypertensive, alpha-antagonist, and diuretic properties; a modified naphthofuran-xylose.Formula:C28H28O11Color and Shape:SolidMolecular weight:540.52OncoFAP
CAS:OncoFAP is an ultra-high affinity fibroblast activating protein (FAP) ligand with potential tumour targeting.Formula:C21H19F2N5O5Purity:99.77%Color and Shape:SolidMolecular weight:459.402R,4S-Sacubitril
CAS:2R,4S-Sacubitril (Sacubitril Enantiomer) is the impurity of Sacubitril which is a neprilysin inhibitor.Formula:C24H28NO51CaPurity:98%Color and Shape:SolidMolecular weight:430.49NPR-C activator 1
CAS:NPR-C activator 1 is an activator of the natriuretic peptide receptor C (NPR-C), which can be used to study cardiovascular diseases.Formula:C18H24N6O3Purity:98.74%Color and Shape:SolidMolecular weight:372.42BAY-850 HCl
BAY-850 is a selective probe targeting Atad2A's bromine domain, displacing acetylated H4 peptides and detaching ATAD2 from chromatin at 1μm.Formula:C38H48Cl5N5O3Color and Shape:SolidMolecular weight:800.08CLK1/4-IN-1
CLK1/4-IN-1 inhibits Clk1/4 (IC50: 9.7/6.6 nM), curbing T24 cell growth (GI50: 1.1 μM). Potential cancer research tool.Formula:C18H14ClNO4SColor and Shape:SolidMolecular weight:375.83ATM Inhibitor-4
ATM Inhibitor -4: selective, potent (IC50: 0.32 nM), inhibits PI3K family, stable, stops mTOR at 1 μM.Formula:C26H29FN6O3Color and Shape:SolidMolecular weight:492.55
